. Table 1 Selected bond lengths and angles for compounds Q7 and Q9. 
Blood coagulation activities

Q5
-11.43±0.13*** -10.22±0.13*** -9.67±0*** -4.03±0.23*** -2.28±0.13***
Q6
-4.57±0.48*** -4.70±0.13*** -6.99±0.13*** -9.54±0.13*** -14.79±0.13***
Q7
-3.57±0.28*** -4.40±0.16*** -5.38±0.33*** -6.85±0.16*** -7.83±0.33***
Q8
-1.61±0.13*** -4.29±0*** -3.89±0.23*** -4.83±0.27*** -1.21±0.13***
Q9
-9.82±0.27*** -6.72±0.13*** -5.19±0.13*** -4.03±0.23*** -3.90±0.27*** Data represent mean ± SEM; n = 8.
* P < 0.05 vs. PAMBA; ** P < 0.01 vs. PAMBA; *** P < 0.001 vs. PAMBA. Compound Q2 significantly shortened the APTT (P < 0.001; Table 2 ) and exhibited a minimum APTT value (R APTT = -38.84 ± 0.08%; Table 2), while significantly shortening the TT (R TT = -24.52 ± 0.24%, 50 μmol/L, P < 0.001; Table  4 ) and the PT (R PT = -6.79 ± 0.15%, 1 μmol/L, P < 0.001; Table 3 ). The blood coagulant activities results demonstrated that compound Q2 showed significantly shortened APTT, PT and TT than the positive control of PAMBA.
